Telomerase-specific T-cells kill pancreatic tumor cells in vitro and in vivo

Cancer

Volumn 106, Issue 4, 2006, Pages 759-764

  Schmidt, Jan ^a   Ryschich, Eduard ^a   Sievers, Elisabeth ^b   Schmidt Wolf, Ingo G H ^b   Büchler, Markus W ^a   Märten, Angela ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Adoptive cell transfer; Antigen specific T cells; Nonmyeloablative chemotherapy; Pancreatic carcinoma; Telomerase

Indexed keywords

CYCLOPHOSPHAMIDE; FREUND ADJUVANT; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA ANTIGEN; PEPTIDE; TELOMERASE;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; CANCER INHIBITION; CANCER MODEL; CELL KILLING; CONTROLLED STUDY; CYTOTOXICITY; DENDRITIC CELL; FEASIBILITY STUDY; HLA MATCHING; HUMAN; HUMAN CELL; IMMUNIZATION; IN VITRO STUDY; IN VIVO STUDY; INJECTION; MOUSE; NONHUMAN; PANCREAS CARCINOMA; PRIORITY JOURNAL; SPLEEN; T LYMPHOCYTE; TREATMENT INDICATION;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, NEOPLASM; ANTINEOPLASTIC AGENTS, ALKYLATING; CARCINOMA; CYCLOPHOSPHAMIDE; DENDRITIC CELLS; DISEASE PROGRESSION; INFUSIONS, INTRAVENOUS; MALE; MICE; MICE, INBRED C57BL; PANCREATIC NEOPLASMS; SPLEEN; T-LYMPHOCYTES; TELOMERASE; TUMOR CELLS, CULTURED;

EID: 32544432871     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21655     Document Type: Article

References (15)

1. Raraty MG, Magee CJ, Ghaneh P, Neoptolemos JP. New techniques and agents in the adjuvant therapy of pancreatic cancer. Acta Oncol. 2002;41:582-595.
2. Picozzi VJ, Kozarek RA, Traverso LW. Interferon-based adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am J Surg. 2003;185:476-480.
3. Jaffee EM, Hruban RH, Biedrzycki B, et al. Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation. J Clin Oncol. 2001;19:145-156.
4. Dudley ME, Rosenberg SA. Adoptive-cell-transfer therapy for the treatment of patients with cancer. Nat Rev Cancer. 2003;3:666-675.
5. Dudley ME, Wunderlich JR, Yang JC, et al. Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J Clin Oncol. 2005;23:2346-2357.
6. Rosenberg SA, Yannelli JR, Yang JC, et al. Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2. J Natl Cancer Inst. 1994;86:1159-1166.
7. Dudley ME, Wunderlich JR, Yang JC, et al. A phase I study of nonmyeloablative chemotherapy and adoptive transfer of autologous tumor antigen-specific T lymphocytes in patients with metastatic melanoma. J Immunother. 2002;25:243-251.
8. Dudley ME, Wunderlich J, Nishimura MI, et al. Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma. J Immunother. 2001;24:363-373.
9. Vonderheide RH, Hahn WC, Schultze JL, Nadler LM. The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes. Immunity. 1999;10:673-679.
10. Vonderheide RH, Anderson KS, Hahn WC, Butler MO, Schultze JL, Nadler LM. Characterization of HLA-A3-restricted cytotoxic T lymphocytes reactive against the widely expressed tumor antigen telomerase. Clin Cancer Res. 2001;7:3343-3348.
11. Arai J, Yasukawa M, Ohminami H, Kakimoto M, Hasegawa A, Fujita S. Identification of human telomerase reverse transcriptase-derived peptides that induce HLA-A24-restricted antileukemia cytotoxic T lymphocytes. Blood. 2001;97:2903-2907.
12. Frolkis M, Fischer MB, Wang Z, Lebkowski JS, Chiu CP, Majumdar AS. Dendritic cells reconstituted with human telomerase gene induce potent cytotoxic T-cell response against different types of tumors. Cancer Gene Ther. 2003;10:239-249.
13. Sievers E, Albers P, Schmidt-Wolf IG, Marten A. Telomerase pulsed dendritic cells for immunotherapy for renal cell carcinoma. J Urol. 2004;171:114-119.
14. Mizumoto K, Tanaka M. Detection of telomerase activity in patients with pancreatic cancer. Methods Mol Med. 2004;103:199-206.
15. Schneider C, Schmidt T, Ziske C, et al. Tumor suppression induced by macrophage activating lipopeptide in an ultrasound-guided syngeneic pancreatic carcinoma mouse model. Gut. 2003;53:355-363.